Emerald Development Managers logo

Emerald Development Managers

North America, New York, United States, New York

Description

Emerald Development Managers LP is a New York-based venture capital firm specializing in early-stage growth equity investments. Established to provide capital and strategic support to promising companies, the firm primarily targets sectors such as technology, healthcare, and financial services. Their investment approach is characterized by a long-term perspective, aiming to partner with management teams to scale innovative businesses and drive significant value creation. The firm's focus on 'early-stage growth equity' indicates a preference for companies that have moved beyond the initial startup phase but are still in a high-growth trajectory, requiring substantial capital to accelerate expansion.

The firm typically seeks out companies that have demonstrated initial traction and are poised for significant market expansion. They are known for their hands-on approach, offering operational expertise and network access to their portfolio companies, which is crucial for businesses navigating rapid growth. Emerald Development Managers often participates in syndicated rounds, co-investing alongside other reputable venture capital firms and institutional investors. This collaborative strategy allows them to deploy substantial capital while leveraging collective insights and mitigating risk across their investment portfolio.

While specific portfolio details are proprietary, public records indicate their involvement in various high-growth companies. For example, they have participated in funding rounds where companies raised significant capital, such as a Series B round totaling $20 million for a healthcare technology firm, or a Series C round exceeding $40 million for a fintech innovator. These investments underscore their commitment to fostering innovation and driving market disruption across their core sectors. Their typical first check size ranges from approximately $5 million to $25 million, reflecting their focus on providing meaningful growth capital to companies transitioning from early-stage development to market leadership.

Investor Profile

Emerald Development Managers has backed more than 39 startups, with 4 new investments in the last 12 months alone. The firm has led 8 rounds, about 21% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Seed, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States, United Kingdom, Canada.
  • Strong thematic focus on Biotechnology, Cyber Security, Medical.
  • Led 3 rounds in the past year.
  • Typical check size: $5M – $25M.

Stage Focus

  • Series A (33%)
  • Seed (21%)
  • Series Unknown (18%)
  • Series B (15%)
  • Series C (10%)
  • Series D (3%)

Country Focus

  • United States (95%)
  • United Kingdom (3%)
  • Canada (3%)

Industry Focus

  • Biotechnology
  • Cyber Security
  • Medical
  • Health Care
  • Artificial Intelligence (Ai)
  • Information Technology
  • Software
  • Cloud Security
  • Security
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Emerald Development Managers frequently co-invest with?

Razor's Edge Ventures
North America, Virginia, United States, Reston
Co-Investments: 4
Evolution Equity Partners
North America, New York, United States, New York
Co-Investments: 3
Alpha Intelligence Capital
Europe, Luxembourg, Luxembourg, Luxembourg
Co-Investments: 3
CIG Spectrum Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 9
Robin Hood Ventures
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 4
GR
North America, New York, United States, Harrison
Co-Investments: 5
Prelude Fund
North America, Utah, United States, Salt Lake City
Co-Investments: 3
Ten Eleven Ventures
North America, California, United States, Burlingame
Co-Investments: 3
RRE Ventures
North America, New York, United States, New York
Co-Investments: 3
SoGal Ventures
North America, New York, United States, New York
Co-Investments: 3

Which angels does Emerald Development Managers often collaborate with?

AP
North America, New York, United States, New York
Shared Deals: 1
CT
Europe, Zurich, Switzerland
Shared Deals: 1
Shared Deals: 1
MF
North America, California, United States, Mountain View
Shared Deals: 1
AW
Europe, Zurich, Switzerland
Shared Deals: 1
ZL
North America, Texas, United States, Austin
Shared Deals: 1
JV
North America, New Jersey, United States, Deal
Shared Deals: 1
Dan Amiga
Asia, Tel Aviv, Israel, Tel Aviv
Shared Deals: 1

What are some of recent deals done by Emerald Development Managers?

Una Software

Toronto, Ontario, Canada

Una Software is a SaaS company that offers an AI driven software for performance planning for finance teams.

Enterprise SoftwareSaaSSoftware
SeedMay 8, 2025
Amount Raised: $4,400,000
Uviquity

Raleigh, North Carolina, United States

Uviquity is a firm that wants to encourage safety for their clients.

Artificial Intelligence (AI)Cyber SecuritySaaS
SeedMay 7, 2025
Amount Raised: $6,600,000
Proscia

Philadelphia, Pennsylvania, United States

Proscia develops digital pathology software designed to help laboratories and life sciences organizations manage and analyze pathology data.

Artificial Intelligence (AI)BiotechnologyLife ScienceMedical
Series DMar 19, 2025
Amount Raised: $50,000,000
Uviquity

Raleigh, North Carolina, United States

Uviquity is a firm that wants to encourage safety for their clients.

Artificial Intelligence (AI)Cyber SecuritySaaS
Series UnknownSep 5, 2024
Amount Raised: $6,674,620
Proscia

Philadelphia, Pennsylvania, United States

Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.

Artificial Intelligence (AI)BiotechnologyLife ScienceMedical
Series CJan 11, 2024
Amount Raised: $9,000,000
ETCH

Chevy Chase, Maryland, United States

ETCH commercializes a chemical process that generates low-cost hydrogen by splitting natural gas into hydrogen and solid carbon.

ChemicalGreenTechIndustrial
SeedJul 25, 2023
Amount Raised: $7,500,000
Cyware

Jersey City, New Jersey, United States

Cyware provides cyber fusion solutions to help businesses detect and stop cyberattacks.

Cloud SecurityCyber SecurityInformation TechnologySecurity
Series CJun 29, 2023
Amount Raised: $30,000,000
Transcend Therapeutics

Waltham, Massachusetts, United States

Transcend Therapeutics offers novel pharmaceuticals for the critical care market.

BiotechnologyHealth CarePharmaceutical
Series AFeb 23, 2023
Amount Raised: $40,000,000
Torigen Pharmaceuticals

Farmington, Connecticut, United States

Torigen Pharmaceuticals focuses on providing cancer care solutions for animals.

BiotechnologyHealth CareOncologyVeterinary
Series ANov 16, 2022
Amount Raised: $13,000,000
Evolved By Nature

Medford, Massachusetts, United States

Evolved By Nature is a biotech company that focuses on creating Activated Silk technology.

BiotechnologyChemicalProduct ResearchSustainability
Series CJun 28, 2022
Amount Raised: $120,000,000